Sinovac Biotech, Ltd. · NASDAQ:SVA

Vivo Capital IX, LLC reported a 6.30% stake in Sinovac Biotech, Ltd. (Schedule 13D/A)

Event Apr 23, 2025 · Filed Apr 24, 2025

Vivo Capital IX, LLC reported a 6.30% stake in Sinovac Biotech, Ltd., 4,539,456 shares, with active intent on Apr 23, 2025. Filed Apr 24, 2025 (Schedule 13D/A).

Stake
6.30%
Shares
4,539,456
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Vivo Capital VIII, LLC1.90%1,360,544
Vivo Capital IX, LLC6.30%4,539,456

Source

View original at SEC

Related